Moderna Unveiled Promising Coronavirus Vaccine Results. Then Top Execs Dumped Nearly $30mn of Stock


The sales occurred after Moderna (MRNA) excited Wall Street before markets opened Monday by announcing encouraging vaccine trial results. Moderna's market value swelled to $29 billion -- even though the company has no marketed products.

Image: CNN
Image
Moderna's stock price skyrocketed as much as 30% on Monday after the biotech company announced promising early results for its coronavirus vaccine. As ordinary investors piled in, two insiders were quietly heading for the exits.
Moderna's chief financial officer and chief medical officer executed options and sold nearly $30 million of shares combined on Monday and Tuesday,
The sales occurred after Moderna (MRNA) excited Wall Street before markets opened Monday by announcing encouraging vaccine trial results. Moderna's market value swelled to $29 billion -- even though the company has no marketed products.
After spiking to as high as $87 on Monday, Moderna's stock price has since retreated below $70 as medical experts have debated the importance of the early findings.

Comments

Popular posts from this blog

How to Learn Data science from scratch

TikTok's ratings went upto 4.4 stars on Play Store after Google removed 8 million negative reviews

Facebook CatchUp is new group calling app, 5 things to know